Published in Infect Immun on September 01, 1974
Assay of Escherichia coli heat-labile enterotoxin with vero cells. Infect Immun (1977) 4.37
Membrane receptors for bacterial toxins. Microbiol Rev (1983) 2.41
Rabbit intestinal glycoprotein receptor for Escherichia coli heat-labile enterotoxin lacking affinity for cholera toxin. Infect Immun (1982) 2.08
Activation of adenylate cyclase by heat-labile Escherichia coli enterotoxin. Evidence for ADP-ribosyltransferase activity similar to that of choleragen. J Clin Invest (1978) 2.07
Immunological interrelationships between cholera toxin and the heat-labile and heat-stable enterotoxins of coliform bacteria. Infect Immun (1977) 1.67
Pathophysiological effects of Vibrio cholerae and enterotoxigenic Escherichia coli and their exotoxins on eucaryotic cells. Microbiol Rev (1978) 1.39
Gangliosides sensitize unresponsive fibroblasts to Escherichia coli heat-labile enterotoxin. J Clin Invest (1979) 1.27
Type II heat-labile enterotoxin of Escherichia coli activates adenylate cyclase in human fibroblasts by ADP ribosylation. Infect Immun (1987) 1.09
Immunological relationship of different preparations of coliform enterotoxins. Infect Immun (1978) 0.95
Inhibition of enterotoxin from Escherichia coli and Vibrio cholerae by gangliosides from human milk. Infect Immun (1983) 0.90
Stimulation of cyclic AMP secretion in Vero cells by enterotoxins of Escherichia coli and Vibrio cholerae. Infect Immun (1978) 0.76
Interaction of cholera enterotoxin with cultured adrenal tumor cells. Infect Immun (1975) 0.76
Cholera toxin-induced tolerance to allografts in mice. Immunology (1987) 0.75
Protein measurement with the Folin phenol reagent. J Biol Chem (1951) 1743.91
A protein binding assay for adenosine 3':5'-cyclic monophosphate. Proc Natl Acad Sci U S A (1970) 23.79
Differences in the response of rabbit small intestine to heat-labile and heat-stable enterotoxins of Escherichia coli. Infect Immun (1973) 8.47
A heat-labile enterotoxin from strains of Eschericha coli enteropathogenic for pigs. J Infect Dis (1969) 7.19
Enterotoxigenic Escherichia coli isolated from patients with severe cholera-like disease. J Infect Dis (1971) 7.10
Stimulation of adenyl cyclase by Escherichia coli enterotoxin. Nat New Biol (1972) 6.65
Comparison of the tissue receptors for Vibrio cholerae and Escherichia coli enterotoxins by means of gangliosides and natural cholera toxoid. Infect Immun (1973) 6.58
Stimulation of intestinal mucosal adenyl cyclase by cholera enterotoxin and prostaglandins. J Clin Invest (1971) 6.09
Multiple cyclic nucleotide phosphodiesterase activities from rat brain. Biochemistry (1971) 5.78
Immunologic cross-reactions of enterotoxins from Escherichia coli and Vibrio cholerae. J Infect Dis (1973) 5.46
Toxigenic Escherichia coli: a cause of infantile diarrhea in Chicago. N Engl J Med (1972) 5.45
Interaction of Vibrio cholerae enterotoxin with cell membranes. Biochemistry (1973) 4.84
Gangliosides and membrane receptors for cholera toxin. Biochemistry (1973) 4.81
Stimulation of jejunal secretion by a crude Escherichia coli enterotixin. Gastroenterology (1972) 4.02
Relationships among heat-labile enterotoxins of Escherichia coli and Vibrio cholerae. J Infect Dis (1974) 3.66
Cellular recognition by mouse lymphocytes in vitro. I. Definition of a new technique and results of stimulation by phytohemagglutinin and specific antigens. J Exp Med (1970) 3.55
Stimulation of intestinal adenyl cyclase by Escherichia coli enterotoxin: comparison of strains from an infant and an adult with diarrhea. J Infect Dis (1974) 2.52
Interaction of cholera toxin and toxin derivatives with lymphocytes. I. Binding properties and interference with lectin-induced cellular stimulation. J Exp Med (1974) 2.42
Differential inhibitory effects of cholera toxoids and ganglioside on the enterotoxins of Vibrio cholerae and Escherichia coli. J Exp Med (1973) 2.38
Effect of Escherichia coli on fluid transport across canine small bowel. Mechanism and time-course with enterotoxin and whole bacterial cells. J Clin Invest (1973) 2.25
Adenyl cyclase in fat cells. II. Hormone receptors. J Biol Chem (1969) 2.20
Effects of cholera enterotoxin on adenosine 3',5'-monophosphate and neutrophil function. Comparison with other compounds which stimulate leukocyte adenyl cyclase. J Clin Invest (1973) 2.16
Effects of prostaglandins and cholera enterotoxin on intestinal mucosal cyclic AMP accumulation. Evidence against an essential role for prostaglandins in the action of toxin. J Clin Invest (1974) 1.89
Separation of cyclic 3',5'-nucleoside monophosphates from other nucleotides on aluminum oxide columns. Application to the assay of adenyl cyclase and guanyl cyclase. Anal Biochem (1971) 1.83
Effects of cholera and E. coli enterotoxins on cyclic adenosine 3',5'-monophosphate levels and intermediary metabolism in the thyroid. Endocrinology (1973) 1.59
Sequence of events mediating the effect of cholera toxin on rat thymocytes. J Clin Invest (1974) 1.07
Effects of prostaglandins on hepatic adenylate cyclase activity and cyclic adenosine 3',5',-monophosphate content. Endocrinology (1974) 0.89
Specific prostaglandin E1 and A1 binding sites in rat adipocyte plasma membranes. Biochim Biophys Acta (1973) 0.86
Separation of cyclic 3',5'-nucleoside monophosphates from other nucleotides on aluminum oxide columns. Application to the assay of adenyl cyclase and guanyl cyclase. Anal Biochem (1971) 1.83
Rapid solid-phase radioimmunoassay for staphylococcal enterotoxin A. Appl Microbiol (1973) 1.70
A protein from polymorphonuclear leukocytes (LEM) which affects the rate of hepatic amino acid transport and synthesis of acute-phase globulins. Endocrinology (1975) 1.57
A rapid solid phase radioimmunoassay for staphylococcal B enterotoxin. J Immunol (1972) 1.54
Production, purification, and chemical characterization of Staphylococcus aureus exfoliative toxin. Infect Immun (1975) 1.44
Evidence for cell-receptor activity in lymphocyte stimulation by staphylococcal enterotoxin. J Immunol (1975) 1.35
DDAVP (1-desamino-8-D-arginine-vasopressin) treatment of central diabetes insipidus--mechanism of prolonged antidiuresis. J Clin Endocrinol Metab (1978) 1.27
On the cross-reactivity of staphylococcal enterotoxins A, B, and C. J Immunol (1978) 1.22
Detection of Clostridium botulinum type G toxin by enzyme-linked immunosorbent assay. Appl Environ Microbiol (1981) 1.18
Staphylococcus aureus enterotoxin B release (excretion) under controlled conditions of fermentation. Appl Microbiol (1973) 1.15
Intrinsic and chemically produced microheterogeneity of Staphylococcus aureus enterotoxin type C. Infect Immun (1975) 1.09
Fractionation and purification of Staphylococcus aureus enterotoxin B by electrofocusing. Biochim Biophys Acta (1972) 1.06
Toxin production by Clostridium botulinum type A under various fermentation conditions. Appl Environ Microbiol (1979) 1.03
Inhibition of cholera toxin-stimulated intestinal epithelial cell adenylate cyclase by adenosine analogs. Proc Soc Exp Biol Med (1976) 0.99
Antigenicity of formaldehyde-inactivated staphylococcal enterotoxin B. J Immunol (1973) 0.99
Role of cyclic adenosine 3',5'-monophosphate in lymphocyte mitogenesis. J Immunol (1974) 0.98
Biological activity and complementation of the two peptides of staphylococcal enterotoxin B formed by limited tryptic hydrolysis. J Biol Chem (1975) 0.97
Effect of age on intestinal calcium absorption and adaptation to dietary calcium. Am J Physiol (1979) 0.96
Effects of calcium on prostaglandin E2 synthesis by rat inner medullary slices. Am J Physiol (1978) 0.96
Effect of vitamin D metabolites on intestinal calcium absorption and calcium-binding protein in young and adult rats. Endocrinology (1980) 0.94
Effect of single peptide bond scission by trypsin on the structure and activity of staphylococcal enterotoxin B. J Biol Chem (1973) 0.93
Effect of single and double peptide bond scission by trypsin on the structure and activity of staphylococcal enterotoxin C. J Biol Chem (1976) 0.92
Benzidine binding to nucleic acids mediated by the peroxidative activity of prostaglandin endoperoxide synthetase. Cancer Res (1980) 0.92
Metabolic activation of carcinogenic aromatic amines by dog bladder and kidney prostaglandin H synthase. Cancer Res (1984) 0.91
Human-derived immune globulins for the treatment of botulism. Rev Infect Dis (1980) 0.89
Effects of prostaglandins on hepatic adenylate cyclase activity and cyclic adenosine 3',5',-monophosphate content. Endocrinology (1974) 0.89
Effect of leukocytic endogenous mediators on endocrine pancreas secretory responses. Am J Physiol (1977) 0.88
Effect of acetaminophen on prostaglandin E2 and prostaglandin F2alpha synthesis in the renal inner medulla of rat. Biochim Biophys Acta (1978) 0.88
Inhibition of glucagon-mediated increases in hepatic cyclic adenosine 3', 5'-monophosphate by prostaglandin E1 and E2. Endocrinology (1974) 0.87
Adaptation to dietary calcium and phosphorus restriction changes with age in the rat. Am J Physiol (1980) 0.87
Infection-induced hyperglucagonemia and altered hepatic response to glucagon in the rat. Am J Physiol (1974) 0.87
Prostaglandin E2 production by rabbit urinary bladder. Am J Physiol (1980) 0.87
Prostaglandin endoperoxide synthetase-mediated metabolism of carcinogenic aromatic amines and their binding to DNA and protein. Biochem Biophys Res Commun (1982) 0.86
Effects of calcium and A23187 on renal inner medullary prostaglandin E2 synthesis. Am J Physiol (1980) 0.86
Glucuronidation of benzidine and its metabolites by cDNA-expressed human UDP-glucuronosyltransferases and pH stability of glucuronides. Carcinogenesis (1999) 0.86
Control of hepatic glycogen metabolism in the rhesus monkey: effect of glucose, insulin, and glucagon administration. Am J Physiol (1975) 0.85
The role of acetylation in benzidine metabolism and DNA adduct formation in dog and rat liver. Chem Res Toxicol (1995) 0.84
Acidic urine pH is associated with elevated levels of free urinary benzidine and N-acetylbenzidine and urothelial cell DNA adducts in exposed workers. Cancer Epidemiol Biomarkers Prev (1997) 0.84
Effect of oxygen and solute on PGE and PGF production by rat kidney slices. Prostaglandins (1977) 0.84
The impact of interindividual variation in NAT2 activity on benzidine urinary metabolites and urothelial DNA adducts in exposed workers. Proc Natl Acad Sci U S A (1996) 0.83
Effect of PTH and 1,25(OH)2D3 on renal 25(OH)D3 metabolism, adenylate cyclase, and protein kinase. Am J Physiol (1984) 0.83
Differential distribution of the mixed-function oxidase activities in rabbit kidney. J Pharmacol Exp Ther (1978) 0.83
Glucuronide conjugates of 4-aminobiphenyl and its N-hydroxy metabolites. pH stability and synthesis by human and dog liver. Biochem Pharmacol (1996) 0.82
Prostaglandin hydroperoxidase-mediated 2-amino-4-(5-nitro-2-furyl) [14C]thiazole metabolism and nucleic acid binding. Cancer Res (1981) 0.82
Cooxidation of benzidine by renal medullary prostaglandin cyclooxygenase. J Pharmacol Exp Ther (1979) 0.82
Inhibition by aspirin of N-[4-(5-nitro-2-furyl)-2-thiazolyl] formamide-induced bladder carcinogenesis and enhancement of forestomach carcinogenesis. Carcinogenesis (1984) 0.82
Impaired inner medullary production of prostaglandin E2 in the kidney of the myxedematous rat. Endocrinology (1978) 0.81
N-acetylbenzidine and N,N'-diacetylbenzidine formation by rat and human liver slices exposed to benzidine. Carcinogenesis (1995) 0.81
Metabolism of benzidine by a prostaglandin-mediated process in renal inner medullary slices. J Pharmacol Exp Ther (1980) 0.81
Effect of age on the conversion of 25-hydroxyvitamin D3 to 1,25-dihydroxyvitamin D3 by kidney of rat. J Clin Invest (1980) 0.81
Urinary mutagenicity as a biomarker in workers exposed to benzidine: correlation with urinary metabolites and urothelial DNA adducts. Carcinogenesis (1997) 0.81
Nitrating reactive nitric oxygen species transform acetaminophen to 3-nitroacetaminophen. Chem Res Toxicol (2000) 0.81
Formation of adenosine 3',5'-monophosphate from adenosine in mouse thymocytes. Biochim Biophys Acta (1975) 0.81
Aspirin inhibition of N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide-induced lesions of the urinary bladder correlated with inhibition of metabolism by bladder prostaglandin endoperoxide synthetase. Cancer Res (1981) 0.81
Forskolin increases 1,25-dihydroxyvitamin D3 production by rat renal slices in vitro. Endocrinology (1984) 0.81
Isothermal denaturation of aqueous staphylococcal enterotoxin B by guanidine hydrochloride, urea, and acid pH. Biochemistry (1974) 0.81
Prostaglandin H synthase-catalyzed activation of benzidine: a model to assess pharmacologic intervention of the initiation of chemical carcinogenesis. J Pharmacol Exp Ther (1983) 0.81
Metabolism and action of the prostaglandin endoperoxide PGH2 in rat kidney. Biochem Biophys Res Commun (1977) 0.81
Radioimmunoassay for quantitation of antibodies to alphaviruses with staphylococcal protein A. J Clin Microbiol (1978) 0.80
Transport of the renal carcinogen 3-hydroxymethyl-1-([3-(5-nitro-2-furyl)allydidene]amino) hydantoin by renal cortex and cooxidative metabolism by prostaglandin endoperoxide synthetase. Cancer Res (1981) 0.80
Eicosanoid synthesis by cultured human urothelial cells: potential role in bladder cancer. Cancer Res (1986) 0.80
6-Ketoprostaglandin E1 stimulation of rat and rabbit renal adenylate cyclase-cyclic AMP systems. Biochim Biophys Acta (1981) 0.80
Glucuronidation of N-hydroxy metabolites of N-acetylbenzidine. Carcinogenesis (1995) 0.80
Mechanism of inhibition of renal prostaglandin production by acetaminophen. J Pharmacol Exp Ther (1979) 0.80
N-acetylbenzidine-N'-glucuronidation by human, dog and rat liver. Carcinogenesis (1993) 0.79
Modulation of the cyclic AMP content of rat renal inner medulla by oxygen: possible role of local prostaglandins. J Clin Invest (1976) 0.79
Staphylococcal enterotoxin A (SEA). Methods Enzymol (1981) 0.79
Solute concentration affects bradykinin-mediated increases in renal prostaglandin E2. Endocrinology (1981) 0.79
DNA adducts formed by ring-oxidation of the carcinogen 2-naphthylamine with prostaglandin H synthase in vitro and in the dog urothelium in vivo. Carcinogenesis (1985) 0.79
Mechanism of formation and structural characterization of DNA adducts derived from peroxidative activation of benzidine. Carcinogenesis (1988) 0.79
Evaluation of renal concentrating and diluting ability. Clin Lab Med (1993) 0.79
Metabolism and disposition of bladder carcinogens in rat and guinea pig: possible mechanism of guinea pig resistance to bladder cancer. Cancer Res (1991) 0.79
Effect of fermentation conditions on toxin production by Clostridium botulinum type B. Appl Environ Microbiol (1980) 0.79
Demonstration of separate pathways for the metabolism of organic compounds in rabbit kidney. J Pharmacol Exp Ther (1979) 0.78
Kidney metabolism of acetaminophen and phenacetin. J Lab Clin Med (1978) 0.78
Renal cytochrome P-450's-electrophoretic and electron paramagnetic resonance studies. Arch Biochem Biophys (1979) 0.78
Renal growth in response to unilateral ureteral obstruction. Kidney Int (1983) 0.78
The glutathione S-transferase M1 (GSTM1) null genotype and benzidine-associated bladder cancer, urine mutagenicity, and exfoliated urothelial cell DNA adducts. Cancer Epidemiol Biomarkers Prev (1996) 0.78
Metabolic activation of the carcinogen N-[4-(5-nitro-2-furyl)-2-thiazolyl]acetamide by prostaglandin H synthase. Carcinogenesis (1984) 0.77
Prostaglandin H synthase oxidation of benzidine and o-dianisidine: reduction and conjugation of activated amines by thiols. Carcinogenesis (1985) 0.77
Differential inhibition of cyclic AMP and cyclic GMP hydrolysis in rat renal cortex. Arch Biochem Biophys (1977) 0.77
Metabolism of N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide by prostaglandin endoperoxide synthetase. Cancer Res (1980) 0.77
Comparison of the effects of prostaglandin I2 and prostaglandin E2 stimulation of the rat kidney adenylate cyclase-cyclic AMP systems. Biochim Biophys Acta (1979) 0.77
Cortical interstitial cell interactions induce sensitivity of hydronephrotic kidney to bradykinin. Kidney Int (1988) 0.77
Effects of hypophysectomy and growth hormone treatment on renal hydroxylation of 25-hydroxycholecalciferol in rats. J Endocrinol (1984) 0.77
N-Acetylbenzidine-DNA adduct formation by phorbol 12-myristate-stimulated human polymorphonuclear neutrophils. Chem Res Toxicol (2000) 0.77
Effect of aspirin on metabolism of acetaminophen and benzidine by renal inner medulla prostaglandin hydroperoxidase. J Lab Clin Med (1983) 0.77
Cooxygenation by prostaglandin cyclooxygenase from rabbit inner medulla. Kidney Int (1979) 0.77
Role of N-glucuronidation in benzidine-induced bladder cancer in dog. Carcinogenesis (1992) 0.77
Anaerobic metabolism and nuclear binding of the carcinogen 2-amino-4-(5-nitro-2-furyl)thiazole (ANFT). Carcinogenesis (1982) 0.77
Effect of dietary calcium and phosphorus restriction on calcium and phosphorus balance in young and old rats. Arch Biochem Biophys (1981) 0.77
Effects of prostaglandin H2, prostaglandin E2, and arachidonic acid on parathyroid hormone and antidiuretic hormone activation of rat kidney adenylate cyclase. Metabolism (1980) 0.77
Inhibition by aspirin of N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide initiation and sodium saccharin promotion of urinary bladder carcinogenesis in male F344 rats. Cancer Res (1986) 0.77
The effect of long-term administration of aspirin and sodium saccharin on the rat kidney. Toxicol Appl Pharmacol (1986) 0.77
Metabolism of aromatic and heterocyclic amine bladder carcinogens: bioanalytical considerations. J Pharm Biomed Anal (1990) 0.77
Enzyme systems involved in the formation of reactive metabolites in the renal medulla: cooxidation via prostaglandin H synthase. Fundam Appl Toxicol (1984) 0.77
Renal metabolism of drugs and xenobiotics. Nephron (1981) 0.77
Neurohypophyseal peptides in hypothyroid rats: plasma levels and kidney response. Metabolism (1979) 0.77
Prostaglandin H synthase metabolism of the urinary bladder carcinogens benzidine and ANFT. Carcinogenesis (1983) 0.77
Prostaglandin hydroperoxidase-catalyzed activation of certain N-substituted aryl renal and bladder carcinogens. Environ Health Perspect (1983) 0.76